Interprofessional Antimicrobial Stewardship Influencing

broad-spectrum antibiotics clindamycin diagnosis infection control multidisciplinary

Journal

Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216

Informations de publication

Date de publication:
2019
Historique:
received: 13 05 2019
accepted: 18 10 2019
entrez: 7 12 2019
pubmed: 7 12 2019
medline: 7 12 2019
Statut: epublish

Résumé

To reduce This was an observational study. CDI was defined as stool samples or Of a total 50,970 patients, 1,750 patients underwent The integrated antimicrobial, diagnostic, and infection control approach used in ipAS may reduce CDIs.

Identifiants

pubmed: 31807031
doi: 10.2147/IDR.S184050
pii: 184050
pmc: PMC6839804
doi:

Types de publication

Journal Article

Langues

eng

Pagination

3409-3414

Informations de copyright

© 2019 Yoshida et al.

Déclaration de conflit d'intérêts

Junichi Yoshida reports funds from Sanofi Aventis, MSD, and Astellas Co. for the clinical trials of CDI. Masao Tanaka reports grants from Olympus Inc., outside the submitted work. The authors report no other conflicts of interest in this work.

Références

Surg Infect (Larchmt). 2017 Nov/Dec;18(8):846-853
pubmed: 29173054
Int J Antimicrob Agents. 2005 Jan;25(1):1-10
pubmed: 15620820
JAMA Intern Med. 2016 Dec 01;176(12):1801-1808
pubmed: 27723860
Infect Control Hosp Epidemiol. 2018 Dec;39(12):1406-1411
pubmed: 30322417
PLoS One. 2017 Jun 16;12(6):e0179117
pubmed: 28622340
Infect Drug Resist. 2019 Nov 04;12:3409-3414
pubmed: 31807031
Int J Clin Pract. 2012 Oct;66(10):999-1008
pubmed: 22846073
PLoS One. 2014 Jun 09;9(6):e99101
pubmed: 24911244
Infection. 2016 Jun;44(3):395-439
pubmed: 27066980
Int J Infect Dis. 2018 Dec;77:34-39
pubmed: 30292892
Clin Microbiol Infect. 2014 Oct;20(10):954-62
pubmed: 25294340
Am J Infect Control. 2018 Jan;46(1):103-104
pubmed: 28754222
Infection. 2015 Aug;43(4):405-12
pubmed: 25588968
Am J Infect Control. 2016 Dec 1;44(12):1684-1686
pubmed: 27908435
JAMA. 2017 Feb 28;317(8):807-808
pubmed: 28114630
Emerg Med J. 2015 Jul;32(7):509-15
pubmed: 25261006
Am J Infect Control. 1999 Apr;27(2):97-132; quiz 133-4; discussion 96
pubmed: 10196487
Int J Clin Pract. 2018 Nov 10;:e13293
pubmed: 30414352
Am J Infect Control. 2019 Apr;47(4):406-408
pubmed: 30502111
J Am Coll Surg. 2019 Apr;228(4):570-580
pubmed: 30739011
J Antimicrob Chemother. 2018 Feb 1;73(2):517-526
pubmed: 29177477
Am J Infect Control. 2016 Feb;44(2):210-4
pubmed: 26521703
Am J Infect Control. 2018 Mar;46(3):276-284
pubmed: 29269166
J Clin Microbiol. 2017 Nov;55(11):3306-3307
pubmed: 29066567

Auteurs

Junichi Yoshida (J)

Division of Infection Control, Shimonoseki City Hospital, Shimonoseki, Japan.

Tetsuya Kikuchi (T)

Division of Infection Control, Shimonoseki City Hospital, Shimonoseki, Japan.

Takako Ueno (T)

Division of Infection Control, Shimonoseki City Hospital, Shimonoseki, Japan.

Akiko Mataga (A)

Division of Infection Control, Shimonoseki City Hospital, Shimonoseki, Japan.

Ikuyo Asano (I)

Division of Infection Control, Shimonoseki City Hospital, Shimonoseki, Japan.

Kazuhiro Otani (K)

Division of Infection Control, Shimonoseki City Hospital, Shimonoseki, Japan.

Tetsuro Tamura (T)

Division of Infection Control, Shimonoseki City Hospital, Shimonoseki, Japan.

Masao Tanaka (M)

Division of Infection Control, Shimonoseki City Hospital, Shimonoseki, Japan.

Classifications MeSH